Gastric Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have provided written informed consent based on sufficient explanation, thorough understanding, and their own free will. Patients aged 20 years or older but under 75 years at the time of consent. Patients diagnosed with clinically resectable gastric cancer at stage I-III. Patients scheduled for informed consent for elective surgery Patients for whom the principal investigator or sub-investigators confirm that the attending physician can clearly present the treatment plan during the initial consultation based on prior diagnostic results.
Exclusion criteria
Exclusion criteria: Patients with a history of gastric cancer surgery (e.g., remnant gastric cancer patients). Patients classified as Grade 3 or higher by the American Society of Anesthesiologists (ASA). Patients are scheduled for neoadjuvant chemotherapy (NAC). Patients with comorbid psychiatric disorders, psychological symptoms, or cognitive impairment, were deemed unable to participate in the study. Patients or accompanying family members unable to operate the MediOS system. Any other patients deemed unsuitable by the principal investigator or sub-investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decisional Conflict Scale Score | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Informed Consent Time Change in Total Time Required for Outpatient Consultations Surgery-related Parameters: Operative Time, Blood Loss, Postoperative Complications Exploratory Evaluation Items | — |
Countries
Japan
Contacts
Fujita Health University Department of Surgery